Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

OSLER-RENDU-WEBER SYNDROME 2

Known as: HHT2, Telangiectasia, hereditary hemorrhagic, type 2 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
To describe clinical presentations of hereditary hemorrhagic telangiectasia (HHT) patients in Japan. There were 80 patients (40… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 3
2014
2014
Activin A receptor, type II-like kinase 1 (ALK1 is a serine-threonine kinase) predominantly expressed on endothelial cells… Expand
  • figure 1
2012
2012
Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disease characterised by vascular dysplasia and increased… Expand
  • figure 1
  • figure 6
Highly Cited
2006
Highly Cited
2006
Hereditary hemorrhagic telangiectasia (HHT) is a genetically heterogeneous vascular dysplasia with multiple telangiectases and… Expand
2006
2006
To the Editor: The identification of underlying causal genes in familial forms of cerebrovascular malformations allows the… Expand
Highly Cited
2003
Highly Cited
2003
Background: Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant vascular dysplasia characterised by… Expand
Highly Cited
1996
Highly Cited
1996
Hereditary haemorrhagic telangiectasia (HHT) is a genetically heterogeneous dominant disorder. Two disease loci have been mapped… Expand